Sector ratings IRLAB Therapeutics AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 08/05/2026 BST			5-day change	1st Jan Change
1.258 ^SEK	+0.16%		-10.65%	-36.14%

05-06	IRLAB Q1 operating result swings to profit of SEK 10.7 mln	RE
05-06	Irlab reports growth in revenue and operating profit	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
IRLAB THERAPEUTICS AB	11.59M	-	-	-		-	-	-
ELI LILLY AND COMPANY	846B		A
JOHNSON & JOHNSON	533B		BBB
ABBVIE INC.	356B	-	AA	-		-
ROCHE HOLDING AG	324B		AA
ASTRAZENECA PLC	282B		A
NOVARTIS AG	278B		AAA
MERCK & CO., INC.	275B		A
NOVO NORDISK A/S	203B		A
AMGEN INC.	179B		A
GILEAD SCIENCES, INC.	163B		AA
PFIZER INC.	146B		A
BRISTOL-MYERS SQUIBB COMPANY	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	109B		AA
SANOFI	103B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	83.01B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.58B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.53B		AA
Average	213.14B		AA
Weighted average by Cap.			AA